Global Ranitidine (Zantac) Market Growth 2020-2025


  • Sep 2020
  • |
  • 159
  • |
  • Pharmaceuticals and Healthcare

According to this study, over the next five years the Ranitidine (Zantac) market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Ranitidine (Zantac) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Ranitidine (Zantac) market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Ranitidine (Zantac), covering the supply chain analysis, impact assessment to the Ranitidine (Zantac) market size growth rate in several scenarios, and the measures to be undertaken by Ranitidine (Zantac) companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Ranitidine Capsule

Ranitidine Oral Tablet

Ranitidine Injectable Solution

Ranitidine Oral Syrup

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Sanofi-Aventis

PAI Holdings, LLC

GlaxoSmithKline

Sun Pharma

Mylan Pharmaceuticals Inc. (and Mylan Laboratories)

Hi-Tech Pharmacal Co.

Strides (and Strides Arcolab international)

Dr. Reddy’s Laboratories Inc.

Geri-Care Pharmaceuticals

Sandoz Inc. (part of Novartis AG)

Teva Pharmaceuticals

Apotex Inc. (and Apotex Corporation)

Glenmark Pharmaceuticals (and Glenmark Generics)

Hikma Pharmaceuticals (West-ward Pharmaceuticals)

Granules Pharmaceuticals Inc.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Ranitidine (Zantac) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Ranitidine (Zantac) market by identifying its various subsegments.

Focuses on the key global Ranitidine (Zantac) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Ranitidine (Zantac) with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Ranitidine (Zantac) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ranitidine (Zantac) Consumption 2015-2025

2.1.2 Ranitidine (Zantac) Consumption CAGR by Region

2.2 Ranitidine (Zantac) Segment by Type

2.2.1 Ranitidine Capsule

2.2.2 Ranitidine Oral Tablet

2.2.3 Ranitidine Injectable Solution

2.2.4 Ranitidine Oral Syrup

2.3 Ranitidine (Zantac) Consumption by Type

2.3.1 Global Ranitidine (Zantac) Consumption Market Share by Type (2015-2020)

2.3.2 Global Ranitidine (Zantac) Revenue and Market Share by Type (2015-2020)

2.3.3 Global Ranitidine (Zantac) Sale Price by Type (2015-2020)

2.4 Ranitidine (Zantac) Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 Online Pharmacy

2.5 Ranitidine (Zantac) Consumption by Application

2.5.1 Global Ranitidine (Zantac) Consumption Market Share by Type (2015-2020)

2.5.2 Global Ranitidine (Zantac) Value and Market Share by Type (2015-2020)

2.5.3 Global Ranitidine (Zantac) Sale Price by Type (2015-2020)

3 Global Ranitidine (Zantac) by Company

3.1 Global Ranitidine (Zantac) Sales Market Share by Company

3.1.1 Global Ranitidine (Zantac) Sales by Company (2018-2020)

3.1.2 Global Ranitidine (Zantac) Sales Market Share by Company (2018-2020)

3.2 Global Ranitidine (Zantac) Revenue Market Share by Company

3.2.1 Global Ranitidine (Zantac) Revenue by Company (2018-2020)

3.2.2 Global Ranitidine (Zantac) Revenue Market Share by Company (2018-2020)

3.3 Global Ranitidine (Zantac) Sale Price by Company

3.4 Global Ranitidine (Zantac) Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Ranitidine (Zantac) Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Ranitidine (Zantac) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Ranitidine (Zantac) by Regions

4.1 Ranitidine (Zantac) by Regions

4.2 Americas Ranitidine (Zantac) Consumption Growth

4.3 APAC Ranitidine (Zantac) Consumption Growth

4.4 Europe Ranitidine (Zantac) Consumption Growth

4.5 Middle East & Africa Ranitidine (Zantac) Consumption Growth

5 Americas

5.1 Americas Ranitidine (Zantac) Consumption by Countries

5.1.1 Americas Ranitidine (Zantac) Consumption by Countries (2015-2020)

5.1.2 Americas Ranitidine (Zantac) Value by Countries (2015-2020)

5.2 Americas Ranitidine (Zantac) Consumption by Type

5.3 Americas Ranitidine (Zantac) Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Ranitidine (Zantac) Consumption by Regions

6.1.1 APAC Ranitidine (Zantac) Consumption by Regions (2015-2020)

6.1.2 APAC Ranitidine (Zantac) Value by Regions (2015-2020)

6.2 APAC Ranitidine (Zantac) Consumption by Type

6.3 APAC Ranitidine (Zantac) Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Ranitidine (Zantac) by Countries

7.1.1 Europe Ranitidine (Zantac) Consumption by Countries (2015-2020)

7.1.2 Europe Ranitidine (Zantac) Value by Countries (2015-2020)

7.2 Europe Ranitidine (Zantac) Consumption by Type

7.3 Europe Ranitidine (Zantac) Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Ranitidine (Zantac) by Countries

8.1.1 Middle East & Africa Ranitidine (Zantac) Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Ranitidine (Zantac) Value by Countries (2015-2020)

8.2 Middle East & Africa Ranitidine (Zantac) Consumption by Type

8.3 Middle East & Africa Ranitidine (Zantac) Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Ranitidine (Zantac) Distributors

10.3 Ranitidine (Zantac) Customer

11 Global Ranitidine (Zantac) Market Forecast

11.1 Global Ranitidine (Zantac) Consumption Forecast (2021-2025)

11.2 Global Ranitidine (Zantac) Forecast by Regions

11.2.1 Global Ranitidine (Zantac) Forecast by Regions (2021-2025)

11.2.2 Global Ranitidine (Zantac) Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Ranitidine (Zantac) Forecast by Type

11.8 Global Ranitidine (Zantac) Forecast by Application

12 Key Players Analysis

12.1 Sanofi-Aventis

12.1.1 Company Information

12.1.2 Ranitidine (Zantac) Product Offered

12.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Sanofi-Aventis Latest Developments

12.2 PAI Holdings, LLC

12.2.1 Company Information

12.2.2 Ranitidine (Zantac) Product Offered

12.2.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 PAI Holdings, LLC Latest Developments

12.3 GlaxoSmithKline

12.3.1 Company Information

12.3.2 Ranitidine (Zantac) Product Offered

12.3.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 GlaxoSmithKline Latest Developments

12.4 Sun Pharma

12.4.1 Company Information

12.4.2 Ranitidine (Zantac) Product Offered

12.4.3 Sun Pharma Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Sun Pharma Latest Developments

12.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)

12.5.1 Company Information

12.5.2 Ranitidine (Zantac) Product Offered

12.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Latest Developments

12.6 Hi-Tech Pharmacal Co.

12.6.1 Company Information

12.6.2 Ranitidine (Zantac) Product Offered

12.6.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Hi-Tech Pharmacal Co. Latest Developments

12.7 Strides (and Strides Arcolab international)

12.7.1 Company Information

12.7.2 Ranitidine (Zantac) Product Offered

12.7.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Strides (and Strides Arcolab international) Latest Developments

12.8 Dr. Reddy’s Laboratories Inc.

12.8.1 Company Information

12.8.2 Ranitidine (Zantac) Product Offered

12.8.3 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Dr. Reddy’s Laboratories Inc. Latest Developments

12.9 Geri-Care Pharmaceuticals

12.9.1 Company Information

12.9.2 Ranitidine (Zantac) Product Offered

12.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Geri-Care Pharmaceuticals Latest Developments

12.10 Sandoz Inc. (part of Novartis AG)

12.10.1 Company Information

12.10.2 Ranitidine (Zantac) Product Offered

12.10.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Sandoz Inc. (part of Novartis AG) Latest Developments

12.11 Teva Pharmaceuticals

12.11.1 Company Information

12.11.2 Ranitidine (Zantac) Product Offered

12.11.3 Teva Pharmaceuticals Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Teva Pharmaceuticals Latest Developments

12.12 Apotex Inc. (and Apotex Corporation)

12.12.1 Company Information

12.12.2 Ranitidine (Zantac) Product Offered

12.12.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Apotex Inc. (and Apotex Corporation) Latest Developments

12.13 Glenmark Pharmaceuticals (and Glenmark Generics)

12.13.1 Company Information

12.13.2 Ranitidine (Zantac) Product Offered

12.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Latest Developments

12.14 Hikma Pharmaceuticals (West-ward Pharmaceuticals)

12.14.1 Company Information

12.14.2 Ranitidine (Zantac) Product Offered

12.14.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Latest Developments

12.15 Granules Pharmaceuticals Inc.

12.15.1 Company Information

12.15.2 Ranitidine (Zantac) Product Offered

12.15.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2018-2020)

12.15.4 Main Business Overview

12.15.5 Granules Pharmaceuticals Inc. Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Ranitidine (Zantac) Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Ranitidine Capsule

Table 5. Major Players of Ranitidine Oral Tablet

Table 6. Major Players of Ranitidine Injectable Solution

Table 7. Major Players of Ranitidine Oral Syrup

Table 8. Global Consumption Sales by Type (2015-2020)

Table 9. Global Ranitidine (Zantac) Consumption Market Share by Type (2015-2020)

Table 10. Global Ranitidine (Zantac) Revenue by Type (2015-2020) ($ million)

Table 11. Global Ranitidine (Zantac) Value Market Share by Type (2015-2020) ($ Millions)

Table 12. Global Ranitidine (Zantac) Sale Price by Type (2015-2020)

Table 13. Global Consumption Sales by Application (2015-2020)

Table 14. Global Ranitidine (Zantac) Consumption Market Share by Application (2015-2020)

Table 15. Global Ranitidine (Zantac) Value by Application (2015-2020)

Table 16. Global Ranitidine (Zantac) Value Market Share by Application (2015-2020)

Table 17. Global Ranitidine (Zantac) Sale Price by Application (2015-2020)

Table 18. Global Ranitidine (Zantac) Sales by Company (2017-2019) (K Units)

Table 19. Global Ranitidine (Zantac) Sales Market Share by Company (2017-2019)

Table 20. Global Ranitidine (Zantac) Revenue by Company (2017-2019) ($ Millions)

Table 21. Global Ranitidine (Zantac) Revenue Market Share by Company (2017-2019)

Table 22. Global Ranitidine (Zantac) Sale Price by Company (2017-2019)

Table 23. Global Ranitidine (Zantac) Manufacturing Base Distribution and Sales Area by Manufacturers

Table 24. Players Ranitidine (Zantac) Products Offered

Table 25. Ranitidine (Zantac) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 26. Global Ranitidine (Zantac) Consumption by Regions 2015-2020 (K Units)

Table 27. Global Ranitidine (Zantac) Consumption Market Share by Regions 2015-2020

Table 28. Global Ranitidine (Zantac) Value by Regions 2015-2020 ($ Millions)

Table 29. Global Ranitidine (Zantac) Value Market Share by Regions 2015-2020

Table 30. Americas Ranitidine (Zantac) Consumption by Countries (2015-2020) (K Units)

Table 31. Americas Ranitidine (Zantac) Consumption Market Share by Countries (2015-2020)

Table 32. Americas Ranitidine (Zantac) Value by Countries (2015-2020) ($ Millions)

Table 33. Americas Ranitidine (Zantac) Value Market Share by Countries (2015-2020)

Table 34. Americas Ranitidine (Zantac) Consumption by Type (2015-2020) (K Units)

Table 35. Americas Ranitidine (Zantac) Consumption Market Share by Type (2015-2020)

Table 36. Americas Ranitidine (Zantac) Consumption by Application (2015-2020) (K Units)

Table 37. Americas Ranitidine (Zantac) Consumption Market Share by Application (2015-2020)

Table 38. APAC Ranitidine (Zantac) Consumption by Countries (2015-2020) (K Units)

Table 39. APAC Ranitidine (Zantac) Consumption Market Share by Countries (2015-2020)

Table 40. APAC Ranitidine (Zantac) Value by Regions (2015-2020) ($ Millions)

Table 41. APAC Ranitidine (Zantac) Value Market Share by Regions (2015-2020)

Table 42. APAC Ranitidine (Zantac) Consumption by Type (2015-2020) (K Units)

Table 43. APAC Ranitidine (Zantac) Consumption Market Share by Type (2015-2020)

Table 44. APAC Ranitidine (Zantac) Consumption by Application (2015-2020) (K Units)

Table 45. APAC Ranitidine (Zantac) Consumption Market Share by Application (2015-2020)

Table 46. Europe Ranitidine (Zantac) Consumption by Countries (2015-2020) (K Units)

Table 47. Europe Ranitidine (Zantac) Consumption Market Share by Countries (2015-2020)

Table 48. Europe Ranitidine (Zantac) Value by Countries (2015-2020) ($ Millions)

Table 49. Europe Ranitidine (Zantac) Value Market Share by Countries (2015-2020)

Table 50. Europe Ranitidine (Zantac) Consumption by Type (2015-2020) (K Units)

Table 51. Europe Ranitidine (Zantac) Consumption Market Share by Type (2015-2020)

Table 52. Europe Ranitidine (Zantac) Consumption by Application (2015-2020) (K Units)

Table 53. Europe Ranitidine (Zantac) Consumption Market Share by Application (2015-2020)

Table 54. Middle East & Africa Ranitidine (Zantac) Consumption by Countries (2015-2020) (K Units)

Table 55. Middle East & Africa Ranitidine (Zantac) Consumption Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Ranitidine (Zantac) Value by Countries (2015-2020) ($ Millions)

Table 57. Middle East & Africa Ranitidine (Zantac) Value Market Share by Countries (2015-2020)

Table 58. Middle East & Africa Ranitidine (Zantac) Consumption by Type (2015-2020) (K Units)

Table 59. Middle East & Africa Ranitidine (Zantac) Consumption Market Share by Type (2015-2020)

Table 60. Middle East & Africa Ranitidine (Zantac) Consumption by Application (2015-2020) (K Units)

Table 61. Middle East & Africa Ranitidine (Zantac) Consumption Market Share by Application (2015-2020)

Table 62. Ranitidine (Zantac) Distributors List

Table 63. Ranitidine (Zantac) Customer List

Table 64. Global Ranitidine (Zantac) Consumption Forecast by Countries (2021-2025) (K Units)

Table 65. Global Ranitidine (Zantac) Consumption Market Forecast by Regions

Table 66. Global Ranitidine (Zantac) Value Forecast by Countries (2021-2025) ($ Millions)

Table 67. Global Ranitidine (Zantac) Value Market Share Forecast by Regions

Table 68. Global Ranitidine (Zantac) Consumption Forecast by Type (2021-2025) (K Units)

Table 69. Global Ranitidine (Zantac) Consumption Market Share Forecast by Type (2021-2025)

Table 70. Global Ranitidine (Zantac) Value Forecast by Type (2021-2025) ($ Millions)

Table 71. Global Ranitidine (Zantac) Value Market Share Forecast by Type (2021-2025)

Table 72. Global Ranitidine (Zantac) Consumption Forecast by Application (2021-2025) (K Units)

Table 73. Global Ranitidine (Zantac) Consumption Market Share Forecast by Application (2021-2025)

Table 74. Global Ranitidine (Zantac) Value Forecast by Application (2021-2025) ($ Millions)

Table 75. Global Ranitidine (Zantac) Value Market Share Forecast by Application (2021-2025)

Table 76. Sanofi-Aventis Product Offered

Table 77. Sanofi-Aventis Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 78. Sanofi-Aventis Main Business

Table 79. Sanofi-Aventis Latest Developments

Table 80. Sanofi-Aventis Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 81. PAI Holdings, LLC Product Offered

Table 82. PAI Holdings, LLC Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 83. PAI Holdings, LLC Main Business

Table 84. PAI Holdings, LLC Latest Developments

Table 85. PAI Holdings, LLC Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 86. GlaxoSmithKline Product Offered

Table 87. GlaxoSmithKline Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 88. GlaxoSmithKline Main Business

Table 89. GlaxoSmithKline Latest Developments

Table 90. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 91. Sun Pharma Product Offered

Table 92. Sun Pharma Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 93. Sun Pharma Main Business

Table 94. Sun Pharma Latest Developments

Table 95. Sun Pharma Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 96. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Product Offered

Table 97. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 98. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Main Business

Table 99. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Latest Developments

Table 100. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 101. Hi-Tech Pharmacal Co. Product Offered

Table 102. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 103. Hi-Tech Pharmacal Co. Main Business

Table 104. Hi-Tech Pharmacal Co. Latest Developments

Table 105. Hi-Tech Pharmacal Co. Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 106. Strides (and Strides Arcolab international) Product Offered

Table 107. Strides (and Strides Arcolab international) Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 108. Strides (and Strides Arcolab international) Main Business

Table 109. Strides (and Strides Arcolab international) Latest Developments

Table 110. Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 111. Dr. Reddy’s Laboratories Inc. Product Offered

Table 112. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 113. Dr. Reddy’s Laboratories Inc. Main Business

Table 114. Dr. Reddy’s Laboratories Inc. Latest Developments

Table 115. Dr. Reddy’s Laboratories Inc. Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 116. Geri-Care Pharmaceuticals Product Offered

Table 117. Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 118. Geri-Care Pharmaceuticals Main Business

Table 119. Geri-Care Pharmaceuticals Latest Developments

Table 120. Geri-Care Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 121. Sandoz Inc. (part of Novartis AG) Product Offered

Table 122. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 123. Sandoz Inc. (part of Novartis AG) Main Business

Table 124. Sandoz Inc. (part of Novartis AG) Latest Developments

Table 125. Sandoz Inc. (part of Novartis AG) Basic Information, Company Total Revenue (in $ million), Ranitidine (Zantac) Manufacturing Base, Sales Area and Its Competitors

Table 126. Teva Pharmaceuticals Product Offered

Table 127. Teva Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 128. Teva Pharmaceuticals Main Business

Table 129. Teva Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 130. Teva Pharmaceuticals Latest Developments

Table 131. Apotex Inc. (and Apotex Corporation) Product Offered

Table 132. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 133. Apotex Inc. (and Apotex Corporation) Main Business

Table 134. Apotex Inc. (and Apotex Corporation) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 135. Apotex Inc. (and Apotex Corporation) Latest Developments

Table 136. Glenmark Pharmaceuticals (and Glenmark Generics) Product Offered

Table 137. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 138. Glenmark Pharmaceuticals (and Glenmark Generics) Main Business

Table 139. Glenmark Pharmaceuticals (and Glenmark Generics) Latest Developments

Table 140. Glenmark Pharmaceuticals (and Glenmark Generics) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 141. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Product Offered

Table 142. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 143. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Main Business

Table 144. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Latest Developments

Table 145. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 146. Granules Pharmaceuticals Inc. Product Offered

Table 147. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 148. Granules Pharmaceuticals Inc. Main Business

Table 149. Granules Pharmaceuticals Inc. Latest Developments

Table 150. Granules Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Ranitidine (Zantac)

Figure 2. Ranitidine (Zantac) Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Ranitidine (Zantac) Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Ranitidine (Zantac) Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Ranitidine Capsule

Figure 7. Product Picture of Ranitidine Oral Tablet

Figure 8. Product Picture of Ranitidine Injectable Solution

Figure 9. Product Picture of Ranitidine Oral Syrup

Figure 10. Global Ranitidine (Zantac) Consumption Market Share by Type (2015-2020)

Figure 11. Global Ranitidine (Zantac) Value Market Share by Type (2015-2020)

Figure 12. Ranitidine (Zantac) Consumed in Hospital Pharmacy

Figure 13. Global Ranitidine (Zantac) Market: Hospital Pharmacy (2015-2020) (K Units)

Figure 14. Global Ranitidine (Zantac) Market: Hospital Pharmacy (2015-2020) ($ Millions)

Figure 15. Ranitidine (Zantac) Consumed in Retail Pharmacy

Figure 16. Global Ranitidine (Zantac) Market: Retail Pharmacy (2015-2020) (K Units)

Figure 17. Global Ranitidine (Zantac) Market: Retail Pharmacy (2015-2020) ($ Millions)

Figure 18. Ranitidine (Zantac) Consumed in Online Pharmacy

Figure 19. Global Ranitidine (Zantac) Market: Online Pharmacy (2015-2020) (K Units)

Figure 20. Global Ranitidine (Zantac) Market: Online Pharmacy (2015-2020) ($ Millions)

Figure 21. Global Ranitidine (Zantac) Consumption Market Share by Application (2015-2020)

Figure 22. Global Ranitidine (Zantac) Value Market Share by Application (2015-2020)

Figure 23. Global Ranitidine (Zantac) Sales Market Share by Company in 2017

Figure 24. Global Ranitidine (Zantac) Sales Market Share by Company in 2019

Figure 25. Global Ranitidine (Zantac) Revenue Market Share by Company in 2017

Figure 26. Global Ranitidine (Zantac) Revenue Market Share by Company in 2019

Figure 27. Global Ranitidine (Zantac) Sale Price by Company in 2019

Figure 28. Global Ranitidine (Zantac) Consumption Market Share by Regions 2015-2020

Figure 29. Global Ranitidine (Zantac) Value Market Share by Regions 2015-2020

Figure 30. Americas Ranitidine (Zantac) Consumption 2015-2020 (K Units)

Figure 31. Americas Ranitidine (Zantac) Value 2015-2020 ($ Millions)

Figure 32. APAC Ranitidine (Zantac) Consumption 2015-2020 (K Units)

Figure 33. APAC Ranitidine (Zantac) Value 2015-2020 ($ Millions)

Figure 34. Europe Ranitidine (Zantac) Consumption 2015-2020 (K Units)

Figure 35. Europe Ranitidine (Zantac) Value 2015-2020 ($ Millions)

Figure 36. Middle East & Africa Ranitidine (Zantac) Consumption 2015-2020 (K Units)

Figure 37. Middle East & Africa Ranitidine (Zantac) Value 2015-2020 ($ Millions)

Figure 38. Americas Ranitidine (Zantac) Consumption Market Share by Countries in 2019

Figure 39. Americas Ranitidine (Zantac) Value Market Share by Countries in 2019

Figure 40. Americas Ranitidine (Zantac) Consumption Market Share by Type in 2019

Figure 41. Americas Ranitidine (Zantac) Consumption Market Share by Application in 2019

Figure 42. United States Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 43. United States Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 44. Canada Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 45. Canada Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 46. Mexico Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 47. Mexico Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 48. APAC Ranitidine (Zantac) Consumption Market Share by Countries in 2019

Figure 49. APAC Ranitidine (Zantac) Value Market Share by Regions in 2019

Figure 50. APAC Ranitidine (Zantac) Consumption Market Share by Type in 2019

Figure 51. APAC Ranitidine (Zantac) Consumption Market Share by Application in 2019

Figure 52. China Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 53. China Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 54. Japan Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 55. Japan Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 56. Korea Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 57. Korea Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 58. Southeast Asia Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 59. Southeast Asia Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 60. India Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 61. India Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 62. Australia Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 63. Australia Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 64. Europe Ranitidine (Zantac) Consumption Market Share by Countries in 2019

Figure 65. Europe Ranitidine (Zantac) Value Market Share by Countries in 2019

Figure 66. Europe Ranitidine (Zantac) Consumption Market Share by Type in 2019

Figure 67. Europe Ranitidine (Zantac) Consumption Market Share by Application in 2019

Figure 68. Germany Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 69. Germany Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 70. France Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 71. France Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 72. UK Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 73. UK Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 74. Italy Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 75. Italy Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 76. Russia Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 77. Russia Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 78. Middle East & Africa Ranitidine (Zantac) Consumption Market Share by Countries in 2019

Figure 79. Middle East & Africa Ranitidine (Zantac) Value Market Share by Countries in 2019

Figure 80. Middle East & Africa Ranitidine (Zantac) Consumption Market Share by Type in 2019

Figure 81. Middle East & Africa Ranitidine (Zantac) Consumption Market Share by Application in 2019

Figure 82. Egypt Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 83. Egypt Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 84. South Africa Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 85. South Africa Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 86. Israel Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 87. Israel Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 88. Turkey Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 89. Turkey Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 90. GCC Countries Ranitidine (Zantac) Consumption Growth 2015-2020 (K Units)

Figure 91. GCC Countries Ranitidine (Zantac) Value Growth 2015-2020 ($ Millions)

Figure 92. Global Ranitidine (Zantac) Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 93. Global Ranitidine (Zantac) Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 94. Americas Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 95. Americas Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 96. APAC Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 97. APAC Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 98. Europe Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 99. Europe Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 100. Middle East & Africa Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 101. Middle East & Africa Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 102. United States Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 103. United States Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 104. Canada Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 105. Canada Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 106. Mexico Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 107. Mexico Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 108. Brazil Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 109. Brazil Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 110. China Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 111. China Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 112. Japan Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 113. Japan Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 114. Korea Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 115. Korea Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 116. Southeast Asia Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 117. Southeast Asia Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 118. India Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 119. India Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 120. Australia Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 121. Australia Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 122. Germany Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 123. Germany Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 124. France Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 125. France Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 126. UK Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 127. UK Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 128. Italy Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 129. Italy Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 130. Russia Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 131. Russia Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 132. Spain Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 133. Spain Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 134. Egypt Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 135. Egypt Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 136. South Africa Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 137. South Africa Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 138. Israel Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 139. Israel Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 140. Turkey Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 141. Turkey Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 142. GCC Countries Ranitidine (Zantac) Consumption 2021-2025 (K Units)

Figure 143. GCC Countries Ranitidine (Zantac) Value 2021-2025 ($ Millions)

Figure 144. Sanofi-Aventis Ranitidine (Zantac) Market Share (2018-2020)

Figure 145. PAI Holdings, LLC Ranitidine (Zantac) Market Share (2018-2020)

Figure 146. GlaxoSmithKline Ranitidine (Zantac) Market Share (2018-2020)

Figure 147. Sun Pharma Ranitidine (Zantac) Market Share (2018-2020)

Figure 148. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Market Share (2018-2020)

Figure 149. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Market Share (2018-2020)

Figure 150. Strides (and Strides Arcolab international) Ranitidine (Zantac) Market Share (2018-2020)

Figure 151. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Market Share (2018-2020)

Figure 152. Geri-Care Pharmaceuticals Ranitidine (Zantac) Market Share (2018-2020)

Figure 153. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Market Share (2018-2020)

Figure 154. Teva Pharmaceuticals Ranitidine (Zantac) Market Share (2018-2020)

Figure 155. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Market Share (2018-2020)

Figure 156. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Market Share (2018-2020)

Figure 157. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Market Share (2018-2020)

Figure 158. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Market Share (2018-2020)

Sample Request is not available